All News Vicapsys Life Sciences, Inc.

Equities

VICP

US92560A1060

Market Closed - OTC Markets Other stock markets 10:29:14 2024-05-10 am EDT			5-day change	1st Jan Change
0.444 ^USD	0.00%		-55.15%	-83.80%

2023	Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Vicapsys Life Sciences, Inc. announced that it has received $0.3036 million in funding	23-06-27	CI
Vicapsys Life Sciences, Inc. announced that it expects to receive $0.3036 million in funding	23-06-26	CI
Vicapsys Life Sciences : Change in Certifying Accountants - Form 8-K	23-05-17	PU
VICAPSYS LIFE SCIENCES, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-05-17	AQ
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-14	AQ
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-14	CI
Vicapsys Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt	23-04-13	CI
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-01-12	AQ
NOTE 2 - GOING CONCERN AND MANAGEMENT'S PLANS	22-11-21	AQ
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	22-09-28	AQ
Vicapsys Life Sciences, Inc. Announces Board Changes	22-09-28	CI
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Vicapsys Life Sciences, Inc. Appoints Federico Pier as Chief Executive Officer	22-04-12	CI
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	22-04-12	AQ
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-03-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Vicapsys Life Sciences, Inc.

Equities

VICP

US92560A1060

All News

Filters